Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Review

Clinical Trial

Comparative Study

Research Support, Non-U.S. Gov't

Controlled Clinical Trial

Multicenter Study

Observational Study

Systematic Review

Letter

Case Reports

Clinical Trial Protocol

Publication Year

From

Quick links

Individual year

2026

2024

2023

2022

2021

2020

2019

2017

2014

2013

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Dobutamine""[mesh_terms]

65 Results

Searching titles within these results

Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol.

Michaela Trebs, Ivan Ulč, Günther Krumpl, Pavla Kadlecová, Bernhard Husch, Juri Hodisch

Clinical pharmacology in drug development 2022;11(3):309-317

Full Text

Abstract

Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.

Christopher T Rodgers, Shveta Monga, Ferenc E Mózes, Areesha Nazeer, Betty Raman, Oliver Rider, Ladislav Valkovič, Charalambos Antoniades, Joanne E Milton, Jack J J J Miller, Daniel Massey, Jisoo Lee, Hanan Lamlum, Rury R Holman, Julian L Griffin, Ruth Coleman, Amanda Adler, Moritz J Hundertmark, Masliza Mahmod, Eleanor Wicks, Stefan Neubauer

Circulation 2023;147(22):1654-1669

Free Full Text

Abstract

Dobutamine stress magnetic resonance imaging.

Pairoj Rerkpattanapipat, W Gregory Hundley

Echocardiography (Mount Kisco, N.Y.) 2007;24(3):309-15

Full Text

Abstract

Circulatory support of the sick preterm infant.

I Seri

Seminars in neonatology : SN 2001;6(1):85-95

Full Text

Abstract

Dobutamine-induced spontaneous rhythmic contractions of human isolated atrial strips mimic physiological responses of intact human heart.

A Yenisehirli, O A Elalmis

Methods and findings in experimental and clinical pharmacology 2011;32(8):565-73

Free Full Text

Abstract

The role of Ca++-sensitizers for the treatment of heart failure.

Andreas Lehmann, Joachim Boldt, Jürgen Kirchner

Current opinion in critical care 2004;9(5):337-44

Full Text

Abstract

Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure.

Thierry Le Jemtel, Rohan Samson, Indranee Rajapreyar, Jason Stencel

Current heart failure reports 2022;19(5):364-374

Full Text

Abstract

The effect of inotropes on morbidity and mortality in preterm infants with low systemic or organ blood flow.

N Evans, D A Osborn, M Paradisis

The Cochrane database of systematic reviews 2007;2007(1):CD005090

Free Full Text

Abstract

An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.

Matthias Heringlake, Julian Alvarez, Dominique Bettex, Stefaan Bouchez, Sonja Fruhwald, Massimo Girardis, Elena Grossini, Fabio Guarracino, Antoine Herpain, Wolfgang Toller, Luigi Tritapepe, Piero Pollesello

Expert review of cardiovascular therapy 2021;19(4):325-335

Free Full Text

Abstract

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

F Follath, J G F Cleland, H Just, J G Y Papp, H Scholz, K Peuhkurinen, V P Harjola, V Mitrovic, M Abdalla, E-P Sandell, L Lehtonen

Lancet (London, England) 2002;360(9328):196-202

Full Text

Abstract

Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.

H Duygu, F Ozerkan, M Zoghi, S Nalbantgil, A Yildiz, A Akilli, M Akin, C Nazli, O Ergene

International journal of clinical practice 2008;62(2):228-33

Full Text

Abstract

Classical inotropes and new cardiac enhancers.

Markku Nieminen, Dimitrios Farmakis, John T Parissis

Heart failure reviews 2007;12(2):149-56

Full Text

Abstract

Metabolic effects of norepinephrine and dobutamine in healthy volunteers.

Hermann Ensinger, Wolfgang Geisser, Alexander Brinkmann, Uli Wachter, Josef Vogt, Peter Radermacher, Michael Georgieff, Karl Träger

Shock (Augusta, Ga.) 2003;18(6):495-500

Full Text

Abstract

Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine.

Mehmet Birhan Yilmaz, Kenan Yalta, Can Yontar, Filiz Karadas, Alim Erdem, Okan Onur Turgut, Ahmet Yilmaz, Izzet Tandogan

Cardiovascular drugs and therapy 2008;21(6):431-5

Full Text

Abstract

Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.

Osman Can Yontar, Mehmet Birhan Yilmaz, Alim Erdem, Kenan Yalta, Izzet Tandogan

Arquivos brasileiros de cardiologia 2011;95(6):738-42

Free Full Text

Abstract

Results: 1 – 15 / 65

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Dobutamine""[mesh_terms]

Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol.

Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.

Dobutamine stress magnetic resonance imaging.

Circulatory support of the sick preterm infant.

Dobutamine-induced spontaneous rhythmic contractions of human isolated atrial strips mimic physiological responses of intact human heart.

The role of Ca++-sensitizers for the treatment of heart failure.

Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure.

The effect of inotropes on morbidity and mortality in preterm infants with low systemic or organ blood flow.

An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.

Classical inotropes and new cardiac enhancers.

Metabolic effects of norepinephrine and dobutamine in healthy volunteers.

Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine.

Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.

Results for
""Dobutamine""[mesh_terms]